Healthy Male Volunteers
54
1
1
44
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.7%
2 terminated out of 54 trials
95.7%
+9.2% vs benchmark
2%
1 trials in Phase 3/4
0%
0 of 44 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 44 completed trials
Clinical Trials (54)
Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]GRT6019
A Study to Understand How the Study Medicine (PF-07976016) is Processed and Eliminated in Healthy Men
Pharmacokinetic, Safety and Immunogenicity Phase I Study of HLX14 Versus Prolia® in Healthy Male Subjects
The Effects of Daily Supplementation of Nutriose® on the Fecal Microbiota in Volunteers.
Bioavailability of Pea Protein in Young and Old Volunteers
A Study to Compare the PK , Safety, Tolerability, and Immunogenicity of HLX13 With YERVOY in Male Subjects
A Study to Evaluate the Drug Levels, Physical and Chemical Changes, and Removal of BMS-986196 in Healthy Male Participants
AME Study of [14C]-PC14586 in Healthy Male Participants
Pharmacokinetic Drug Interactions Between HGP1607 and HGP1501
Study to Investigate the Mass Balance and Biotransformation of SIM0417 in Healthy Adult Chinese Male Participants
Compare Pharmacokinetics, Safety, and Immunogenicity of HLX11 vs. Perjeta in Healthy Chinese Male Subjects
Compare Pharmacokinetic, Safety, Tolerability and Immunogenicity of HLX12 and Ramucirumab in Healthy Male Adult Subjects
The Absorption, Metabolism and Excretion of [14C]SH-1028 in Chinese Healthy Male Volunteers
The Effect of Itraconazole and Rifampicin on the Pharmacokinetics of SH-1028
The Study of Pharmacokinetic Interactions Between HL237 and Tacrolimus
An Investigational Study to Determine the Drug Level Profile of BMS-986165 in Healthy Male Volunteers Following Transporter Inhibition.
Drug-drug Interaction Between DWP14012 and Three Different Kinds of NSAIDs
Open-label Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of a Single Oral Dose of [14C]-20 mg/100 μCi Anaprazole Sodium Enteric-coated Capsule in Healthy Adult Male Subjects
A Single Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
Food Effect Study of Anaprazole in Healthy Chinese Subjects